Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1200/JCO.22.02344 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Rethinking how mobile units can catalyze progress on lung cancer screening: a scoping review of what we have learned.
J Thorac Dis
October 2024
Division of Population Health Sciences, Department of Surgery, University of Florida College of Medicine, Gainesville, FL, USA.
Background: Despite United States Preventive Services Task Force (USPSTF) recommendations, low uptake of lung cancer screening (LCS) highlights the need for measures to promote adoption. This scoping review aims to outline the global landscape of mobile low-dose computed tomography (LDCT) platforms, summarizing research and evaluating efficacy in screening at-risk populations.
Methods: We comprehensively searched Cumulative Index to Nursing and Allied Health Literature (CINAHL), PubMed, Embase, Scopus, and Web of Science for articles published between 2017 and 2023.
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2.
J Clin Oncol
December 2024
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
. . , .
View Article and Find Full Text PDFFactors Associated With Default of Treatment and Follow-Up Among Patients With Cancer: A Cross-Sectional Study From a Lower-Middle-Income Country.
JCO Glob Oncol
October 2024
Department of Medical Oncology, Hematology, All India Institute of Medical Sciences, Rishikesh, India.
Purpose: Desirable outcomes during the treatment of patients with cancer require adherence to evaluation, treatment, and follow-up. This study aimed to evaluate the factors associated with default in patients with cancer.
Materials And Methods: We included patients with a histologically confirmed diagnosis of cancer who defaulted during evaluation, treatment, and follow-up.
Standardized assessment of evidence supporting the adoption of mobile health solutions: A Clinical Consensus Statement of the ESC Regulatory Affairs Committee: Developed in collaboration with the European Heart Rhythm Association (EHRA), the Association of Cardiovascular Nursing & Allied Professions (ACNAP) of the ESC, the Heart Failure Association (HFA) of the ESC, the ESC Young Community, the ESC Working Group on e-Cardiology, the ESC Council for Cardiology Practice, the ESC Council of Cardio-Oncology, the ESC Council on Hypertension, the ESC Patient Forum, the ESC Digital Health Committee, and the European Association of Preventive Cardiology (EAPC).
Eur Heart J Digit Health
September 2024
Center for Postgraduate Medical Education, Marymoncka, Warsaw, Poland.
Mobile health (mHealth) solutions have the potential to improve self-management and clinical care. For successful integration into routine clinical practice, healthcare professionals (HCPs) need accepted criteria helping the mHealth solutions' selection, while patients require transparency to trust their use. Information about their evidence, safety and security may be hard to obtain and consensus is lacking on the level of required evidence.
View Article and Find Full Text PDFOral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial.
J Clin Oncol
December 2024
NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.
Article Synopsis
- This clinical trial tested the effectiveness of an oral cannabis extract (THC:CBD) on adults experiencing severe nausea and vomiting from chemotherapy, despite using standard anti-nausea medications.
- The results showed that the cannabis extract significantly increased the rate of complete responses (no vomiting or need for rescue meds) from 8% to 24% compared to a placebo.
- While participants reported some mild side effects like sedation and dizziness, there were no serious adverse events linked to the cannabis treatment.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!